News About: Pharm. Industry
Several small- and medium-sized pharmaceutical firms to form cGMP consortium
Currently, several small- and medium-sized drug manufactures are discussing the formation of a consortium to cope with the current good manufacturing system.
Hanseo Pharm, a chief organizer of such consortium, says...
Drug makers in dilemma to cope with soaring raw material prices in July
Pharmaceutical business sources say that domestic pharmaceutical firms will be in woes to deal with ever-increasing demand of price increase from foreign pharmaceutical bulk manufacturers in China.
“We are quite at...
Schnell Pharm targets W20 bill. sales
Boosted by its active merger with Genexel-Sein and intensive Research and development strategy, Schnell Pharm has set an ambitious goal of 20 billion won in sales next year.
“We will inject money and energy to deve...
Three drug makers to be contested in domestic hepatitis B market
Domestic hepatitis B market will emerge as an arena of tripartite competition - GlaxoSmithKline's Zeffix (lamivudine) and Hepsera (adefovir), Bukwang Pharm's Levovir (clevudine) and BMS Korea's Baraclude (entecavir).
...
Ilaprozole goes on sale in China
Ilyang Pharm says Ilaprazole has been marketed in China since May 16. Ilaprazole 5 mg per tablet is valued at 2,100 won.
Ilyang may get about 18 billion won of annual royalty based on 10% of the net sales until 20...
Boryung Pharm Vice Chairman Kim biggest shareholder
Kim Eun-sun, the first daughter of Boryung Group's chairman Kim Seung-ho, is the second largest shareholder in Boryung Pharm, following the recent shareholding transfer, according to the company's spokesperson.
Cha...
Screening process of medicines under fire
The Health Insurance Review Agency plans to evaluate the economic effectiveness of over 3,000 medicines which belong to six therapeutic categories within this year under the new drug-pricing policy called the positive...
CJ to co-promote Herben, anti-hypertensive product
CJ CheilJedang says it has recently signed an agreement with Mitsubishi Tanabe Pharma Corporation and Welfide Korea to co-market an old-version calcium channel blocker Herben, which was developed by Tanabe Seiyaku and...
Third-party deposit system to take place by September
The new third-party deposit system, which has been actively promoted by the Korea Pharmaceutical Manufacturers Association, will be implemented in September, according to a KPMA official.
The KPMA plans to nurture ...
Korea's technical export revenues surpass $230 million
The nation's total technical export volume has topped $230.8 million over the past five years, with its total technical import volume posting $124.0 million for the cited period, the Korea Drug Research Associat...
